Search results
Aaron is a founder and Managing Partner of Scion. He has spent over a decade specializing in founding, building and investing in life sciences companies, focusing primarily on therapeutics. Aaron currently serves as a board member of Tourmaline Bio (NASDAQ: TRML), where he has been serving since the company’s inception. Previously, he was a ...
Kantoff is a visionary within the life sciences space, specializing in founding, building, and investing in companies dedicated to therapeutics. @northwellhealth @scionlifescience #LedByLustgarten ONE WEEK AWAY! 💜 In honor of Juneteenth, join Erin Billups and renowned researchers for "A Critical Conversation on Pancreatic Cancer Among ...
- 4.9K
Experience: Scion Life Sciences · Education: New York University - Leonard N. Stern School of Business · Location: New York · 500+ connections on LinkedIn. View Aaron Kantoff’s profile on ...
- 500+
- Biotech Investor & Venture Capitalist
- 4.6K
- Scion Life Sciences
Aaron Kantoff, Principal, has significant early and late-stage biotech experience, as well as a background in financial analysis and restructuring. Since joining ATP in 2011, he has been instrumental in helping to create the current investment strategy for the therapeutics team, and has been involved with investing in and building many of the.
- Male
- Apple Tree Partners
- New York
- June 23, 2015
Aaron is a co-founder of RayzeBio and currently serves as a Venture Partner in the Medicxi investment team. Prior to joining Medicxi, Aaron was a partner with Apple Tree Partners (ATP), where he was a key member of the life science investment team since 2011.
Feb 9, 2024 · Aaron Kantoff describes Scion's mission and investment strategy, discusses co-founding RayzeBio, and shares his thoughts on the current state of biotech.